News

Published on 8 Jul 2022 on Zacks via Yahoo Finance

How Much Upside is Left in Forma Therapeutics Holdings, Inc. (FMTX)? Wall Street Analysts Think 379%


Article preview image

Forma Therapeutics Holdings, Inc. (FMTX) closed the last trading session at $8.07, gaining 39.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $38.67 indicates a 379.2% upside potential.

The mean estimate comprises six short-term price targets with a standard deviation of $15.81. While the lowest estimate of $21 indicates a 160.2% increase from the current price level, the most optimistic analyst expects the stock to surge 618.7% to reach $58. It's very important to note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.

While the consensus price target is a much-coveted metric for investors, solely banking on this metric to make an investment decision may not be wise at all. That's because the ability and unbiasedness of analysts in setting price targets have long been questionable.

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Novo Nordisk Touts Another Once-Weekly Insulin Icodec Win In Type 2 Diabetes

Novo Nordisk A/S (NYSE: NVO) has completed posting topline results across its six Phase 3a clinic...

Benzinga via Yahoo Finance 3 Oct 2022

Will Acquisitions Help Novo Nordisk (NVO) Combat Stiff Rivalry?

Denmark-based Novo Nordisk A/S NVO has one of the broadest diabetes portfolios in the industry. T...

Zacks via Yahoo Finance 3 Oct 2022

Biotech Stock Roundup: GILD's Updates, FMTX Up on NVO Deal, SPRO Surges & More

Drug approvals and other regulatory updates are in focus in the biotech sector. The sector is als...

Zacks via Yahoo Finance 7 Sep 2022

Deal Watch: Fried Frank, Dechert, McDermott, Ropes, Skadden All Touch $8B CVS/Signify Deal as M&A...

The end of summer appears to be going out with a bang in big deals. In the past week, there were...

Law.com 6 Sep 2022

Forma Therapeutics Holdings Inc./Novo Nordisk A/S deal, American Airlines Group Inc. cuts flights,...

Today's top business news includes the $1.1 billion acquisition of Forma Therapeutics Holdings In...

The Business Journals 2 Sep 2022

After Pfizer, Now Novo Nordisk Beefs Up Its Sickle Cell Portfolio With Forma Therapeutics Deal

Novo Nordisk A/S (NYSE: NVO) has agreed to acquire Forma Therapeutics Holdings Inc (NASDAQ: FMTX)...

Benzinga via Yahoo Finance 1 Sep 2022

Novo Nordisk to Buy Forma Therapeutics in $1.1 Billion Deal

(Bloomberg) -- Novo Nordisk A/S agreed to buy Forma Therapeutics Holdings Inc. in a deal valuing ...

Bloomberg via Yahoo Finance 1 Sep 2022

Forma Therapeutics to be acquired by Novo Nordisk in a cash deal valued at $1.1 billion

Forma Therapeutics Holdings Inc. announced Thursday and agreement to be acquired by Denmark-based...

MarketWatch 1 Sep 2022

How Much Upside is Left in Forma Therapeutics Holdings, Inc. (FMTX)? Wall Street Analysts Think 379%

Forma Therapeutics Holdings, Inc. (FMTX) closed the last trading session at $8.07, gaining 39.4% ...

Zacks via Yahoo Finance 8 Jul 2022

Can Forma Therapeutics Holdings, Inc. (FMTX) Climb 536% to Reach the Level Wall Street Analysts...

Forma Therapeutics Holdings, Inc. (FMTX) closed the last trading session at $6.08, gaining 9% ove...

Zacks via Yahoo Finance 22 Jun 2022